Tezosentan

Overview

Tezosentan (RO 610612) is an endothelin (ET) receptor antagonist, with pA 2 s of 9.5, 7.7 for ET A and ET B receptors, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Endothelin Receptor

Product Information

• Catalog No.: HY-17351
• CAS No.: 180384-57-0
• Molecular Formula: C27H27N9O6S
• Molecular Weight: 605.63
• Purity: 98.27%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source